UPLOAD Filing
Tango Therapeutics, Inc.
Date: May 20, 2025 · CIK: 0001819133 · Accession: 0000000000-25-005336
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287202
Letter
Re: Tango Therapeutics, Inc. Registration Statement on Form S-3 Filed May 12, 2025 File No. 333-287202 Dear Barbara Weber M.D.:
May 20, 2025
Barbara Weber, M.D. President and Chief Executive Officer Tango Therapeutics, Inc. 201 Brookline Avenue, Suite 901 Boston, MA 02215
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Marishka DeToy, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 20, 2025 Barbara Weber, M.D. President and Chief Executive Officer Tango Therapeutics, Inc. 201 Brookline Avenue, Suite 901 Boston, MA 02215 Re: Tango Therapeutics, Inc. Registration Statement on Form S-3 Filed May 12, 2025 File No. 333-287202 Dear Barbara Weber M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marishka DeToy, Esq. </TEXT> </DOCUMENT>